Michael Sherman, M.D.Senior VP and Chief Medical Officer at Harvard Pilgrim Health Care
Dr. Michael Sherman serves as chief medical officer and senior vice president for health services for Harvard Pilgrim Health Care. A pioneer in developing outcomes-based payment agreements with pharmaceutical companies that go beyond the historical “pay for pill” approach and tie reimbursement to patient outcomes,last year, he signed the first value-based agreement for a gene therapy used to treat a form of blindness and is currently working on a variety of innovative payment models.
Dr. Sherman serves as chair of the Board of Managers of the Harvard Pilgrim Health Care Institute, which encompasses the Department of Population Medicine at Harvard Medical School and on the Advisory Board of the Institute for Clinical and Economic Review (ICER). He also is the immediate past chair for AHIP’s CMO Leadership Council, comprising chief medical officers from health plans throughout the United States, and serves on the board of directors for the Personalized Medicine Coalition.
Prior to joining Harvard Pilgrim, Dr. Sherman held leadership roles at Humana, UnitedHealth Group, and Thomson Medstat (now IBM Truven). He holds a B.A. and an M.S. in biomedical anthropology from the University of Pennsylvania and received his M.D. from Yale and M.B.A. from the Harvard Business School.